Tag Archives: Parkinson’s Disease

A correct diagnosis of Parkinson’s disease (PD) is important for prognosis and therapeutic management, as well as for clinical research.

Table 1: Queen Square Brain Bank UK PDS Brain Bank Criteria for the diagnosis of Parkinson’s disease Step 1 Diagnosis of parkinsonian syndrome – MUST BE PRESENT Bradykinesia (slowness of initiation of voluntary movement with progressive reduction in speed and amplitude or repetitive actions)* and at least one of the following: Muscular rigidity 4- to 6-Hz rest tremor Postural instability

The choice of drugs depends on a risk/benefit evaluation based on: The ability to  improve motor disability (better with levodopa) The risk of motor complications (more common in younger patients; delayed by agonists) The risk of neuropsychiatric complications (more common in older and cognitively impaired patients; greater with agonists) Medications for the treatment of de novo patients MAO-B inhibitors (Level

Company: KRKA Pharma Dublin Ltd.

Company: KRKA Pharma Dublin Ltd.

Aoife Connors reports on how winning an Irish Healthcare Award helped raise awareness of Parkinson’s disease, mental health and a primary care initiative.

Impulse control disorders amongst patients with Parkinson’s disease on dopamine replacement therapy present a “unique opportunity” for research into the neurobiology of impulsive behaviour, researchers say.

Company: Clonmel Healthcare Ireland.

Company: Rowex Ltd.

Patients with early Parkinson’s disease can have subtle deficits in the way they interpret the intentions and feelings of others, which may have an adverse effect on their social interactions and quality of life.